Neidig Brent 4

What Happened

• Brent Neidig, Chief Commercial Officer of USANA Health Sciences (USNA), exercised/converting restricted stock units (RSUs) that settled into 7,310 shares between Feb 6–8, 2026. To satisfy tax withholding, 3,551 of those shares were surrendered at $21.34/share, generating $75,779 in withholding. The filing reports the RSU conversions (derivative items reported at $0.00) and the shares withheld for taxes.

Key Details

• Transaction dates and counts:
  • Feb 6, 2026: 2,219 RSUs converted to 2,219 shares; 1,102 shares withheld for taxes ($21.34/share = $23,517).
  • Feb 7, 2026: 1,401 RSUs converted to 1,401 shares; 696 shares withheld ($21.34/share = $14,853).
  • Feb 8, 2026: 3,690 RSUs converted to 3,690 shares; 1,753 shares withheld ($21.34/share = $37,409).
  • Totals: 7,310 shares acquired from RSU conversion; 3,551 shares withheld; ~$75,779 withheld for taxes.
• Shares owned after the transactions: not specified in the provided filing.
• Footnotes: RSUs convert to one share each (F1); vesting schedules referenced (25% vesting anniversaries per F2–F4).
• Filing timeliness: Form 4 was filed Feb 10, 2026 for Feb 6–8 transactions (no late filing flag noted).

Context

• This was an RSU settlement with net-share (shares withheld) tax withholding — not an open-market sale. The derivative entries at $0.00 reflect cancellation/conversion of the RSU awards into common stock. These routine tax-withholding actions are common when restricted awards vest and do not, by themselves, indicate a change in insider sentiment.